BlackRock Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$1.02B Buy
14,221,079
+1,083,265
+8% +$80.5M 0.48% 38
2016
Q3
$1.04B Buy
13,137,814
+919,000
+8% +$74.7M 0.52% 38
2016
Q2
$1.02B Buy
12,218,814
+252,237
+2% +$22.4M 0.53% 40
2016
Q1
$1.1B Sell
11,966,577
-1,577,378
-12% -$142M 0.59% 31
2015
Q4
$1.37B Buy
13,543,955
+290,329
+2% +$30.2M 0.75% 24
2015
Q3
$1.3B Buy
13,253,626
+1,138,469
+9% +$126M 0.76% 20
2015
Q2
$1.42B Sell
12,115,157
-146,255
-1% -$16M 0.77% 18
2015
Q1
$1.2B Sell
12,261,412
-243,073
-2% -$24.7M 0.65% 24
2014
Q4
$1.18B Buy
12,504,485
+709,349
+6% +$73.4M 0.63% 26
2014
Q3
$1.26B Buy
11,795,136
+41,681
+0.4% +$4.08M 0.73% 21
2014
Q2
$974M Buy
11,753,455
+17,956
+0.2% +$1.4M 0.56% 30
2014
Q1
$832M Sell
11,735,499
-111,392
-0.9% -$8.74M 0.52% 34
2013
Q4
$890M Buy
11,846,891
+94,193
+0.8% +$6.56M 0.57% 34
2013
Q3
$739M Buy
11,752,698
+536,760
+5% +$32.1M 0.5% 37
2013
Q2
$575M Buy
+11,215,938
New +$585M 0.44% 42

Other funds holding GILD

BlackRock Group's GILD Position: Q4 2016 in Review

BlackRock Group increased its Gilead Sciences (GILD) stake by 8.2% in Q4 2016, buying an estimated $80.5M and bringing the position to 14,221,079 shares worth $1.02B. The position accounts for 0.48% of the portfolio, ranked #38.

BlackRock Group first reported a position in GILD in Q2 2013 and has held it in 15 quarters since. The position peaked at $1.42B in Q2 2015. 1,572 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

  • BlackRock Group held 14,221,079 shares of Gilead Sciences worth $1.02B as of Q4 2016.
  • BlackRock Group bought 1,083,265 Gilead Sciences shares in Q4 2016, an estimated $80.5M.
  • Gilead Sciences made up 0.48% of BlackRock Group's portfolio in Q4 2016, its #38 holding.
  • BlackRock Group first reported a position in Gilead Sciences in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Group's Gilead Sciences position peaked at $1.42B in Q2 2015.
  • 1,572 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.